| HOME >> BIOLOGY >> TECHNOLOGY |
6,6667,3711,183Prepaid expenses and other receivables
11,56113,2722,130Trading securities
354--Debt issuance costs
-3,704595Deferred tax assets
5,2685,868942Total current assets897,1721,588,951255,044Property, plant and equipment, net
267,862382,21661,350Non-current prepayments
2,863226,90436,420Non-current accounts receivable, less allowance for doubtful accounts(March 31, 2012: RMB38,628; December 31, 2012: RMB39,384)
254,236248,66339,913Inventories
34,65138,7836,225Intangible assets, net
129,791126,32620,277Available-for-sale equity securities
98,19977,06012,369Other investment
134,363134,36321,567Debt issuance costs
-12,6632,033Deferred tax assets
5,0135,082816Total assets1,824,1502,841,011456,014LIABILITIESCurrent liabilitiesBank loan
45,00050,0008,026Accounts payable
6,34316,9142,715Accrued expenses and other payables
33,35179,29212,728Deferred revenue
106,110147,60823,693Amounts due to related party
360720116Income tax payable
5,9438,3611,342Total current liabilities197,107302,89548,620Convertible notes
-748,075120,074Non-current deferred revenue
306,534474,60576,179Other non-current liabilities
60,42088,83614,259Deferred tax liabilities
24,46223,1913,722Total liabilities588,5231,637,602262,854EQUITYShareholders' equityOrdinary shares-
US$0.0001 par value, 250,000,000 shares authorized, 73,140,147shares issued and outstanding as of March 31, 2012 and 73,140,147 shares issued and 73,003,248 shares outstandingas of December 31, 2012
50508Additional paid-in capital
865,654798,221128,123Treasury stock, at cost
(March 31, 2012: nil; December 31, 2012: 136,899 shares)
-(2,815)(452)Accumulated other comprehensive income
26,0573,297529Retained earnings
310,973400,39264,268Total shareholders' equity1,202,73
'/>"/>
| SOURCE China Cord Blood Corporation Copyright©2012 PR Newswire. All rights reserved |